Switch theme
Sign up to access all valuation multiples
Dr Hoenle AG supplies industrial UV technology. It operates in three business segments: The Adhesive Systems segment in addition to industrial adhesives supplies adhesive curing systems. The Disinfection segment combines activities in the areas of industrial water, surface and air disinfection, including microbiological testing. The Curing segment sells equipment for surface drying and curing paints, varnishes and other coatings. Geographically, the company operates in Germany and other countries. The key revenue portion is from Germany.
1976
590
LTM Revenue $109M
LTM EBITDA $6.5M
$104M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Dr Hoenle has a last 12-month revenue of $109M and a last 12-month EBITDA of $6.5M.
In the most recent fiscal year, Dr Hoenle achieved revenue of $106M and an EBITDA of $3.3M.
Dr Hoenle expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Dr Hoenle valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $114M | $106M | XXX | XXX | XXX |
| Gross Profit | $66.9M | $57.3M | XXX | XXX | XXX |
| Gross Margin | 59% | 54% | XXX | XXX | XXX |
| EBITDA | $0.8M | $3.3M | XXX | XXX | XXX |
| EBITDA Margin | 1% | 3% | XXX | XXX | XXX |
| Net Profit | -$14.4M | -$11.8M | XXX | XXX | XXX |
| Net Margin | -13% | -11% | XXX | XXX | XXX |
| Net Debt | $52.8M | $48.3M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 25, 2025, Dr Hoenle's stock price is EUR 8 (or $9).
Dr Hoenle has current market cap of EUR 49.8M (or $53.5M), and EV of EUR 96.6M (or $104M).
See Dr Hoenle trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $104M | $53.5M | XXX | XXX | XXX | XXX | $-0.96 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 25, 2025, Dr Hoenle has market cap of $53.5M and EV of $104M.
Dr Hoenle's trades at 1.0x LTM EV/Revenue multiple, and 16.0x LTM EBITDA.
Analysts estimate Dr Hoenle's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Dr Hoenle and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $104M | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | 22.1x | XXX | XXX | XXX |
| P/E | -5.1x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 40.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpDr Hoenle's NTM/LTM revenue growth is 8%
Dr Hoenle's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Dr Hoenle's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Dr Hoenle's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Dr Hoenle and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -7% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 4% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 294% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 12% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 69% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Alfen | XXX | XXX | XXX | XXX | XXX | XXX |
| Signify | XXX | XXX | XXX | XXX | XXX | XXX |
| SKS Technologies Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Lion E-Mobility | XXX | XXX | XXX | XXX | XXX | XXX |
| Delta Electronics (Thailand) | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Dr Hoenle acquired XXX companies to date.
Last acquisition by Dr Hoenle was XXXXXXXX, XXXXX XXXXX XXXXXX . Dr Hoenle acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Dr Hoenle founded? | Dr Hoenle was founded in 1976. |
| Where is Dr Hoenle headquartered? | Dr Hoenle is headquartered in Germany. |
| How many employees does Dr Hoenle have? | As of today, Dr Hoenle has 590 employees. |
| Is Dr Hoenle publicy listed? | Yes, Dr Hoenle is a public company listed on ETR. |
| What is the stock symbol of Dr Hoenle? | Dr Hoenle trades under HNL ticker. |
| When did Dr Hoenle go public? | Dr Hoenle went public in 2001. |
| Who are competitors of Dr Hoenle? | Similar companies to Dr Hoenle include e.g. Alfen, Signify, SKS Technologies Group, Lion E-Mobility. |
| What is the current market cap of Dr Hoenle? | Dr Hoenle's current market cap is $53.5M |
| What is the current revenue of Dr Hoenle? | Dr Hoenle's last 12-month revenue is $109M. |
| What is the current EBITDA of Dr Hoenle? | Dr Hoenle's last 12-month EBITDA is $6.5M. |
| What is the current EV/Revenue multiple of Dr Hoenle? | Current revenue multiple of Dr Hoenle is 1.0x. |
| What is the current EV/EBITDA multiple of Dr Hoenle? | Current EBITDA multiple of Dr Hoenle is 16.0x. |
| What is the current revenue growth of Dr Hoenle? | Dr Hoenle revenue growth between 2023 and 2024 was -7%. |
| Is Dr Hoenle profitable? | Yes, Dr Hoenle is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
